Tanzania Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

LSAT prep from HLS-educated instructors LSATMax includes video lessons, unlimited personal attention & support, and over 6,000 real questions from previous LSAT's. Enroll for just $299. From our sponsors

Tanzania Pharmaceuticals and Healthcare Report Q4 2013 Aug 21st 2013, 00:00, by rnrmahesh BMI View: We do not expect Tanzania’s reliance on imported drugs to decrease, even though the government had been encouraging the production of drugs locally. Additionally, export growth will be slow due to the limited capabilities of local drugmakers, which are unable to compete with the greater range of medicines made by multinational generic medicine firms. Headline Expenditure Projections ? Pharmaceuticals: TZS670.79bn (US$423mn) in 2012 to an anticipated TZS740.06bn (US$456mn) in 2013; +10.3% growth in local currency terms and +7.7% in US dollar terms. ? Healthcare: TZS2.71trn (US$1.71bn) in 2012 to TZS3.07trn (US$1.89bn) in 2013; 13.2% growth in local currency … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=111987. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/tanzania-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions